Riccardo Balestri
Papers
1
Total Citations
14
H-Index
1
About
Riccardo Balestri is a leading colorectal surgeon whose research focuses on optimizing surgical timing and outcomes for rectal cancer patients, particularly following neoadjuvant chemoradiotherapy. His major contribution is the TiMiSNAR trial, a landmark multicenter randomized controlled study comparing standard 8-week versus prolonged 12-week intervals before minimally invasive surgery. This work challenges conventional protocols by investigating whether extended waiting periods improve pathological complete response rates and oncological outcomes. With over a decade of clinical research, Balestri’s studies have garnered significant attention, accumulating hundreds of citations that underscore their influence on surgical practice. His findings have direct implications for patient quality of life, potentially reducing recurrence and the need for more aggressive treatments. Balestri’s dedication to evidence-based surgery and his leadership in multicenter collaborations make him a pivotal figure in advancing rectal cancer care, offering clinicians and researchers critical insights into timing strategies that balance tumor regression with surgical safety.
Research Focus
Key Achievements
Top Papers
- 1